Naphazoline HCl Rx
Generic Name and Formulations:
Naphazoline HCl 1mg (0.1%); oph soln; contains benzalkonium chloride.
Indications for Naphazoline HCl:
For use as a topical ocular vasoconstrictor.
Adults and Children:
Instill 1 or 2 drops in the conjunctival sac(s) every 3–4hrs as needed.
Anatomically narrow angle or in narrow-angle glaucoma.
Hypertension. Cardiovascular abnormalities. Diabetes. Hyperthyroidism. Infection. Injury. Children (esp. infants): may result in CNS depression leading to coma and marked reduction in body temperature. Discontinue if no relief obtained within 48hrs of therapy, if irritation, blurring or redness persists or increases, or if symptoms of systemic absorption occur. Pregnancy (Cat.C). Nursing mothers.
Sympathomimetic (imidazoline derivative).
Concomitant maprotiline or tricyclic antidepressants may potentiate pressor effect. Severe hypertensive crisis possible with concomitant MAOIs.
Ocular (eg, mydriasis, increased redness, irritation, discomfort, blurring, punctate keratitis, lacrimation, increased intraocular pressure); systemic (eg, dizziness, headache, nausea, sweating, nervousness, drowsiness, weakness, hypertension, cardiac irregularities, hyperglycemia).
Clinical Pain Advisor Articles
- FDA Takes Steps to Reconcile Needs of Patients With Chronic Pain, Efforts to Curb Opioid Epidemic
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Neuropathic Symptoms Worsen Quality of Life, Function in Hip, Knee Osteoarthritis
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- Switching From Buprenorphine-Naltrexone to XR-Naltrexone as Effective as XR-Naltrexone
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Human Diagnosis Project Aims to Address Challenges Among Uninsured
- Healthcare Technology Affects Younger Patient Satisfaction
- FDA Announces New Drug Shortages Task Force